Emodin coupled with high LET neutron beam—a novel approach to treat on glioblastoma

Author:

Kim Jeong-Yub1,Jung Chan-Woong12,Lee Won Seok3,Jeong Hyeon-Jeong14,Park Myung-Jin1,Jang Won Il5,Kim Eun Ho3

Affiliation:

1. Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences , Seoul 01812 , Republic of Korea

2. Department of Life Sciences, Korea University , 145 Anam-ro Seongbuk-gu, Seoul 02841 , Republic of Korea

3. Department of Biochemistry, School of Medicine, Daegu Catholic University , 33 17-gil, Duryugongwon-ro, Nam-gu 42472, Daegu , Korea

4. School of Biomedical Science, Korea University , 145 Anam-ro Seongbuk-gu, Seoul 02841 , Republic of Korea

5. Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences , Seoul 01812 , Republic of Korea

Abstract

Abstract The primary motivation of this investigative study is trying to find an alternative treatment that can be used to slow down or treat glioblastoma due to the witnessed toxic side effects of the current drugs coupled with limited effectiveness in overall treatment. Consequently, a Chinese plant extract emodin proves to play a critical role in this investigative study since results from the Western blot and the other accompanying assays for anti-cancer effects indicate that it cannot work a lot to suppress cell migration and possible invasion, but rather emodin can be combined with radiation to give desired outcomes. Our result shows that the kind of radiation which acts well with emodin is neutron radiation rather than gamma radiation. Emodin significantly enhanced the radiosensitivity of LN18 and LN428 cells to γ-rays through MTT assay and cell counting. Accordingly, exposure to neutron radiation in the presence of emodin induced apoptotic cell death and autophagic cell death to a significantly higher extent, and suppressed cell migration and invasiveness more robustly. These effects are presumably due to the ability of emodin to amplify the effective dose from neutron radiation more efficiently. Thus, the study below is one such trial towards new interventional discovery and development in relation to glioblastoma treatment.

Funder

National Research Foundation of Korea

Korean Government

Korean Institute of Radiological and Medical Sciences

Ministry of Science and ICT

Publisher

Oxford University Press (OUP)

Subject

Health, Toxicology and Mutagenesis,Radiology, Nuclear Medicine and imaging,Radiation

Reference33 articles.

1. Epidemiologic and molecular prognostic review of glioblastoma;Thakkar;Cancer Epidemiol Biomarkers Prev,2014

2. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents;Minniti;Anticancer Res,2009

3. New strategies to deliver anticancer drugs to brain tumors;Laquintana;Expert Opin Drug Deliv,2009

4. Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics;Dong;Phytother Res,2016

5. Anticancer potential of emodin;Hsu;Biomedicine (Taipei),2012

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3